Back to Search
JOSEPH O'SHAUGHNESSY, PHARMD
PHARMD
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
NPI: 1639564602Individual
Specialties, Licenses & Credentials
Pharmacist Clinician (PhC)/ Clinical Pharmacy SpecialistPrimary
Pharmacist — Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Code: 1835P0018X
20817(NC)
Research & Publications (20)
RiBBON 1 and RiBBON 2: phase III trials of bevacizumab with standard chemotherapy for metastatic breast cancer.
PMID 18757267·Clin Breast Cancer·2008
8-other
Management of febrile neutropenia and cardiac toxicity in the adjuvant treatment of breast cancer.
PMID 18282366·Clin Breast Cancer·2007
6-review
Phase II trial of weekly docetaxel/ gemcitabine as first-line chemotherapy in patients with locally recurrent or metastatic breast cancer.
PMID 16595033·Clin Breast Cancer·2006
3-trial
Capecitabine/Taxane combination therapy: evolving clinical utility in breast cancer.
PMID 16764743·Clin Breast Cancer·2006
6-review
Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy.
PMID 15748464·Clin Breast Cancer·2005
3-trial
Phase II study of pemetrexed in patients pretreated with an anthracycline, a taxane, and capecitabine for advanced breast cancer.
PMID 16001992·Clin Breast Cancer·2005
3-trial
Extending survival with chemotherapy in metastatic breast cancer.
PMID 16368868·Oncologist·2005
6-review
Phase II study of trastuzumab plus gemcitabine in chemotherapy-pretreated patients with metastatic breast cancer.
PMID 15245619·Clin Breast Cancer·2004
3-trial
New perspectives with antimetabolites in the management of breast cancer.
PMID 14754465·Clin Breast Cancer·2004
8-other
Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experience.
PMID 14768400·Oncology (Williston Park)·2003
6-review
Pegylated liposomal doxorubicin in the treatment of breast cancer.
PMID 14715106·Clin Breast Cancer·2003
6-review
Chemotherapy-induced cognitive dysfunction: a clearer picture.
PMID 14705598·Clin Breast Cancer·2003
6-review
Chemotherapy-related cognitive dysfunction in breast cancer.
PMID 14702917·Semin Oncol Nurs·2003
6-review
Primer design for automated DNA sequencing in a core facility.
PMID 12866412·Biotechniques·2003
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2817 ROCK MERRITT AVENUE
FORT BRAGG, NC 28310 - Phone
- (910) 907-8922
Quick Facts
- NPI
- 1639564602
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile